A Phase 2 Study of LY2605541 Compared With Insulin Glargine in the Treatment of Type 1 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 26 Sep 2013 Results of an analysis in patients who underwent euglycaemic clamping (n=23) presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Jul 2013 An Eli Lilly media release announces that an additional analysis exploring reduced mealtime insulin requirements for type 1 diabetes patients treated with insulin peglispro will be presented at the 73rd Annual ADA.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History